期刊文献+

胰高血糖素样肽在重症患者血糖控制中的作用 被引量:5

原文传递
导出
摘要 ICU中的重症患者常合并应激性高血糖,血糖显著升高是危重症患者死亡的独立危险因素,重症患者中合并应激性高血糖的患者甚至较既往有糖尿病史的患者有更高的死亡率[1]。最近10年来,应用外源性胰岛素强化控制血糖显著降低了外科重症患者的术后感染率和多脏器功能障碍的发生率[2-3]。但是,也有越来越多的研究显示强化胰岛素治疗过程中低血糖事件的发生率显著增加而影响患者预后[4-5]。
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第17期1222-1224,共3页 National Medical Journal of China
  • 相关文献

参考文献27

  • 1Norhammar AM,Rydén L,Malmberg K.Admission plasma glucose:independent risk factor for long-term prognosis after myocardial infarction even in nondiabceic patients.Diabetes Care,1999,22:1827-1831.
  • 2Van den Berghe G,Wouters P,Weekers F,et al.Intensive insulin therapy in critically ill patients.N Engl J Med,2001,345:1359-1367.
  • 3Krinsley JS.Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.Mayo Clin Proc,2004,79:992-1000.
  • 4Brunkhorst FM,Engel C,Bloos F,et al.Intensive insulin therapy and pentastarch resuscitation in severe sepsis.N Engl J Med,2008,358:125-139.
  • 5Preiser JC,Devos P,Ruiz-Santana S,et al.A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units:the Glucontrol study.Intensive Care Med,2009,35:1738-1748.
  • 6Deane AM,Chapman MJ,Fraser B J,et al.The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill:a randomized doubleblind placebo-controlled cross over study.Crit Care,2009,13:67.
  • 7Hoist JJ.The physiology of gheagon-like peptide 1.Physiol Bey,2007,87:1409-1439.
  • 8Elabi D.Glucagun-like peptide-1 (9-36) amide,cleavage product of glucagon-like peptide-1 (7-36) is a glucoregulatory peptide.Obesity,2008,16:1501-1509.
  • 9Tomas E,Habener JF.Insulin-like actions of glucagon-like peptide-1:a dual receptor hypothesis.Trends in Endocrin Metabol,2010,21:59-67.
  • 10Little TJ,Pilichiewicz AN,Russo A,et al.Effects of intravenous glucagnn-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects:relation.ships with postprandial glycemic and in sulinemic responses.J Clin Endocrinol Metab,2006,91:1916-1923.

同被引文献36

  • 1曹相原,王晓红,马少林,杨晓军,王晓麒,丁欢,柳明,何兰杰,马晓薇,马希刚.应激性高糖血症与胰岛素抵抗的相关因素研究[J].中国危重病急救医学,2006,18(12):751-754. 被引量:41
  • 2Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia [J] Lancet, 2009, 373 (9677):1798-1807.
  • 3Toft-Nielsen MB, Damholt MB, Madsbad S, et al. Determi- nants of the impaired secretion of glucagon- like peptide- 1 in type 2 diabetic patients [J]. J Glln Endocrinol Metab, 2001, 86 (6) :3717-3723.
  • 4Martindale RG, McClave SA, Vanek VW, et al. Guideiines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition : exec- utive summary [ J ]. Crit Care Med, 2009, 37 (5): 1757-1761.
  • 5Zauner A, Nimmerrichter P, Anderwald C, et al. Severity of insulin resistance in critically ill medical patients [J]. Metabo- lism, 2007, 56 (1) : 1-5.
  • 6VilsbcU T, Krarup T, Deacon CF, et ai. Reduced postprandi- al concentrations of intact biologically active glucagon-like pep- tide 1 in type 2 diabetic patients [ J]. Diabetes, 2001, 50 (3) :609-613.
  • 7Vollmer K, Hoist JJ, Bailer B, et ai. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance [J]. Diabetes, 2008, 57 (3):678-687.
  • 8Padwal R. Glucagon-like peptide-1 agonists [ J ]. BMJ, 2012, 344 :d7282.
  • 9Deane AM, Chapman M J, Fraser RJ, et al. The effect of exog- enous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill : a randomized double- blind placebo-controlled cross over study [J]. Crit Care, 2009, 13 (3) :R67.
  • 10Nauck MA, E1-Ouaghlidi A, Gabrys B, et, al. Secretion of incretin hormones ( GIP and GLP- 1 ) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes [J]. Regul Pept, 2004, 122 (3) :209-217.

引证文献5

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部